APIS Breast Cancer Portfolio

Innovative Solutions for Breast Cancer; Advanced Assays with Precise Results

APIS ESR1 Mutations Kit

  • Wide target coverage – the kit has been designed to cover 11 different ESR1 mutations

  • High specificity - includes clamp and blocking technology to ensure no wild-type detection

  • High sensitivity – all mutations are detected at ≤ 1% MAF (Mutant Allele Frequency)

  • Easy to use – our assays are designed to be user-friendly, with a simple protocol. The reagents have been optimised for precise and sensitive detection in human DNA.

APIS Breast Cancer Subtyping Kit

  • Detecting HER2, ER, PR & Ki67 mRNA expression with high precision and reproducibility

  • Single HER2 resolution method, without the need for reflex testing

  • Novel four-gene signature for measuring proliferation, supporting use of Ki67 alone

  • Automated results interpretation with APIS software

  • Opportunity to enhance HER2 stratification